AGC Biologics | Competitive Intelligence Profile
AGC Biologics is a leading global Contract Development and Manufacturing Organization (CDMO) specializing in the development and...
AGC Biologics is a leading global Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of biopharmaceuticals, including protein-based biologics, cell and gene therapies, viral vectors, plasmid DNA (pDNA), and messenger RNA (mRNA). With cGMP-compliant facilities across the U.S., Europe, and Asia, the company works closely with clients to bring new therapies to market, focusing on improving patients' lives through services such as cell line development, process development, and manufacturing.
🛍️ AGC Biologics Product and Pricing Intelligence →
📅 AGC Biologics Event Participations →
⚖️ AGC Biologics Regulatory Intelligence →
👔 AGC Biologics Management and Leadership Team →
⚔️ AGC Biologics Alternatives and Competitors →
💼 AGC Biologics Hiring and Layoffs →
🤝 AGC Biologics Partnerships, Clients and Vendors →
📈 AGC Biologics Financial Performance, Fundraising, M&A →
🛍️ AGC Biologics Product and Pricing Intelligence
Leverage product insights to define key product development milestones, guide go-to-market planning, build a robust product-market fit matrix, and perform in-depth SWOT analyses.
Harness pricing intelligence to support strategic pricing decisions, conduct competitive pricing analysis, and craft effective differential pricing strategies.
- AGC Biologics Chief Business Officer Christoph Winterhalter discusses how the company is investing in innovation and shortening timelines to help biopharma partners deliver biologics and advanced therapies globally.
📅 AGC Biologics Event Participations
Stay updated on where your competitors are showing up—industry conferences, webinars, podcasts, and speaking engagements—to gauge their messaging, target audiences, and strategic focus. Discover how they’re positioning themselves in the market, what narratives they’re pushing, and which partnerships they’re cultivating. Use this intelligence to refine your own positioning, identify missed opportunities, and stay top-of-mind in your industry.
- AGC Biologics invites attendees to visit booth 6.0B44 with AGC Pharma Chemicals at CPHI Frankfurt 2025 from October 28-30 to discuss mRNA, CGT, or biologics projects with team members including Ben Clauberg, Alexander Ehm, Samuel Neill, Jörg Ohl, Dirk Hoegaerts, Olivier Dezutter, Veera Laine, Christoph Winterhalter, Andrea Porchia, Jen Taillie, Marijana Golubovic, and Ahmed Yahia.
- AGC Biologics will attend CPHI Frankfurt 2025 in booth 6.0B44 with AGC Pharma Chemicals from October 28-30.
- AGC Biologics will connect with attendees at BIO-Europe, November 3-5, in Vienna to discuss protein biologics and advanced therapies development and manufacturing.
⚖️ AGC Biologics Regulatory Intelligence
Monitor critical regulatory events—such as issued or revoked licenses, lawsuits, investigations, and court rulings—to understand the compliance posture and legal exposure of your rivals. Spot early warning signs of operational risk, delays, or reputational damage, and use these insights to fine-tune your market strategy, mitigate your own risk, or capitalize on competitor setbacks.
👔 AGC Biologics Management and Leadership Team
Understand who’s steering your competitors by tracking changes in their management and leadership teams. Gain insights into strategic direction, leadership style, and organizational priorities based on executive backgrounds and hiring trends. Use this knowledge to anticipate competitive moves, tailor your sales or partnership approach, and benchmark against industry leaders.
-
Chief Executive Officer & President
[email protected] -
Executive Assistant to CEO and President Alberto Santagostino[email protected]
-
President and CEO[email protected]
⚔️ AGC Biologics Alternatives and Competitors
Identify the competitors of your competitors to uncover indirect threats, emerging disruptors, and untapped opportunities. Understand the broader competitive ecosystem, spot white space in the market, and gain strategic context that helps you position more effectively. These insights sharpen your market intelligence and reveal angles others often overlook.
- EirGenix |
- Samsung BioLogics |
- KBI Biopharma |
- FUJIFILM Biotechnologies |
- Celltrion |
- Alcami |
- Avid Bioservices |
- Bionova Scientific |
- Rentschler Biopharma |
- Rooted Leaf Agritech |
- Cerevast Medical |
- Bonum Therapeutics |
- Cell Therapies |
- Fujifilm Diosynth Biotechnologies |
- JOINN Biologics |
- Fusion Antibodies |
- XtalPi |
- Kriya Therapeutics |
- Resilience |
- Aldevron |
- Vetter Pharma |
- Mankind Pharma |
- Alembic Pharmaceuticals
💼 AGC Biologics Hiring and Layoffs
Track key workforce changes—new hires, leadership shifts, and layoffs—to spot strategic organizational moves. Identify rising competitors, uncover shifts in company direction, and seize opportunities to attract top talent or engage new decision-makers. Use these insights to refine your recruitment strategy and build stronger business relationships.
- Giuliana Vallanti has joined AGC Biologics as SVP Operations and R&D, Cell and Gene in Italy.
- Cory Pigeon has joined AGC Biologics as Senior Director Business Development in the United States, previously serving as Senior Director Business Development at Recipharm Advanced Bio.
- AGC Biologics is hiring an Associate General Counsel in Denmark to provide legal support for contract negotiations and compliance in the biopharmaceutical industry.
🤝 AGC Biologics Partnerships, Clients and Vendors
Monitor new partnerships, client wins, and vendor relationships to understand where your competitors are gaining traction. Spot emerging alliances, evaluate ecosystem shifts, and identify potential partners or prospects early. These insights help you refine your sales strategy, anticipate market movements, and stay one step ahead in a dynamic competitive landscape.
- AGC Biologics partners with Rarity PBC to provide development and GMP production for the gene therapy RDP-101, which treats bubble baby disease.
📈 AGC Biologics Financial Performance, Fundraising, M&A
Track competitors’ financial performance, fundraising rounds, and M&A activity to assess their growth trajectory and strategic focus. Uncover signals of expansion, market entry, or consolidation, and benchmark your position accordingly. Use these insights to inform investor conversations, identify acquisition opportunities, and fine-tune your competitive strategy.
People also viewed
- SK pharmteco |
- Andelyn Biosciences |
- SimplePractice |
- LG Ad Solutions |
- iSpot.tv |
- TherapyAppointment |
- Sessions Health |
- TVEyes |
- EDO |
- Abacus.AI |
- Airia |
- Mullvad VPN
Ready to outsmart the competition? RivalSense cuts through the clutter of generic tools like Google Alerts, delivering laser-focused competitive intelligence without the noise. Track competitors’ every move—website changes, product updates, social media buzz, news mentions, and regulatory shifts—all in one sleek platform. Uncover pricing strategies, decode market trends, and gain actionable insights to fuel your business strategy. No more guesswork. Just power.
Join thousands of forward-thinking teams who trust RivalSense to automate their competitive monitoring and turn data into domination. Start your FREE trial today—no credit card needed—and see why staying ahead has never been this easy. Your competitors won’t know what hit them.
Outthink. Outpace. Outperform. #RivalSense